All products are for research use only. Not for human consumption.
Selank and Semax come from a research tradition that developed somewhat independently of Western peptide pharmacology. Both were synthesized at Russian institutes during the late Soviet and post-Soviet periods, and both are based on endogenous peptides found in the human body. Despite their shared origin story, their templates, mechanisms, and proposed effects differ.
This article compares the two compounds across origin, mechanism, and modern research interest. Both are intended for research use only.
Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is based on tuftsin — a naturally occurring tetrapeptide fragment of immunoglobulin G — with additional residues added to enhance metabolic stability.
Semax is a synthetic heptapeptide also developed in Russia, derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). The endogenous template is unrelated to Selank's, and the proposed mechanisms reflect this difference.
Selank's tuftsin lineage gives it a connection to immune signaling, but the bulk of preclinical research focuses on its effects on the central nervous system. Studies have examined its modulation of GABAergic and serotonergic systems, with research published in journals including Neuroscience and Behavioral Physiology looking at anxiety-related behavioral models.
Semax research has centered on BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) modulation. Studies published in Doklady Biological Sciences and related journals have documented effects on neurotrophin gene expression in preclinical models. Semax has also been investigated in stroke and ischemia models.
Of the two compounds, Semax has the more substantial published literature on neurotrophin modulation. BDNF is a central regulator of synaptic plasticity, and any compound that influences its expression has obvious appeal as a research tool for investigators studying learning, memory, and neural resilience in preclinical models.
Selank also has BDNF-related literature, but its more frequently studied effects are on anxiolytic-like behavior in rodent models and on the GABA system specifically.
Both peptides are designed for enhanced metabolic stability compared to their endogenous templates. Researchers studying these compounds in animal models often use intranasal administration routes because both peptides have been characterized in this delivery context in published Russian literature.
Although both compounds were developed decades ago, interest in them has expanded internationally as Western researchers gain access to the underlying preclinical literature. Modern studies are increasingly characterizing their effects using the methodologies and reporting standards common in contemporary neuroscience research.
Both compounds remain primarily research tools and are not approved for any therapeutic use outside of specific Russian regulatory contexts that do not extend internationally.
As with any research peptide, Selank and Semax should meet 98%+ HPLC purity with documented Certificate of Analysis from the supplier. Mass spectrometry confirmation of molecular weight is particularly useful for these compounds because their heptapeptide structures can be sensitive to synthesis errors.
Most published Selank and Semax data come from Russian preclinical research. Western replication studies are growing but still limited in number, and many of the underlying mechanistic claims remain to be independently confirmed. Both compounds are sold strictly for laboratory research use only.
Selank is based on tuftsin, a tetrapeptide fragment of immunoglobulin G. Semax is based on a fragment of ACTH (4-10), part of the adrenocorticotropic hormone sequence.
Semax has the more substantial published literature on BDNF and NGF modulation, although both compounds have neurotrophin-related research associated with them.
The forms supplied through international research peptide channels are intended strictly for laboratory research use only and are not approved for human therapeutic use.
Disclaimer: This article is provided for educational and informational purposes only. It does not constitute medical advice. All products referenced are intended strictly for laboratory research use only and are not approved for human consumption.
52 compounds. 99%+ purity. Certificate of Analysis included with every order.